268 related articles for article (PubMed ID: 32535695)
1. Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917.
Xu J; Xia K; Li P; Qian C; Li Y; Liang X
Appl Microbiol Biotechnol; 2020 Aug; 104(15):6731-6747. PubMed ID: 32535695
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the Chromosomal
Gupta K; Tripathi A; Sahu A; Varadarajan R
J Bacteriol; 2017 Oct; 199(19):. PubMed ID: 28674066
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
4. Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.
Jiang Y; Kong Q; Roland KL; Wolf A; Curtiss R
Pathog Dis; 2014 Apr; 70(3):390-400. PubMed ID: 24532573
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP.
Fang K; Jin X; Hong SH
Sci Rep; 2018 Mar; 8(1):4939. PubMed ID: 29563542
[TBL] [Abstract][Full Text] [Related]
6. Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917.
Wu D; Li X; Yu Y; Gong B; Zhou X
Biotechnol Lett; 2021 Jan; 43(1):235-246. PubMed ID: 33011901
[TBL] [Abstract][Full Text] [Related]
7. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Fiege K; Frankenberg-Dinkel N
Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Profiling of the Probiotic
Yim J; Cho SW; Kim B; Park S; Han YH; Seo SW
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290466
[TBL] [Abstract][Full Text] [Related]
9. Identification of a contact-dependent growth inhibition system in the probiotic Escherichia coli Nissle 1917.
Chen H; Fang Q; Tu Q; Liu C; Yin J; Yin Y; Xia L; Bian X; Zhang Y
FEMS Microbiol Lett; 2018 Jun; 365(11):. PubMed ID: 29688444
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the Role of the Type II MqsRA Toxin-Antitoxin System in Stress Response and Biofilm Formation:
Fraikin N; Rousseau CJ; Goeders N; Van Melderen L
mBio; 2019 Dec; 10(6):. PubMed ID: 31848281
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
Hu R; Lin H; Li J; Zhao Y; Wang M; Sun X; Min Y; Gao Y; Yang M
BMC Microbiol; 2020 Aug; 20(1):268. PubMed ID: 32854612
[TBL] [Abstract][Full Text] [Related]
13. Specialised functions of two common plasmid mediated toxin-antitoxin systems, ccdAB and pemIK, in Enterobacteriaceae.
Wu AY; Kamruzzaman M; Iredell JR
PLoS One; 2020; 15(6):e0230652. PubMed ID: 32603331
[TBL] [Abstract][Full Text] [Related]
14. Oleanolic Acid Promotes the Formation of Probiotic
Liu D; Liu J; Ran L; Yang Z; He Y; Yang H; Yu Y; Fu L; Zhu M; Chen H
Microorganisms; 2024 May; 12(6):. PubMed ID: 38930479
[TBL] [Abstract][Full Text] [Related]
15. CRISPRi
Azam MW; Khan AU
Front Nutr; 2022; 9():938989. PubMed ID: 35978963
[TBL] [Abstract][Full Text] [Related]
16. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
[TBL] [Abstract][Full Text] [Related]
17. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
[TBL] [Abstract][Full Text] [Related]
18. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
Raghuvanshi R; Chaudhari A; Kumar GN
Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
